Cargando…
Lymphopenia and Radiation Dose to Circulating Lymphocytes With Neoadjuvant Chemoradiation in Esophageal Squamous Cell Carcinoma
PURPOSE: We hypothesized that radiation-induced lymphopenia could be predicted by the effective dose to the circulating immune cells (EDIC) in advanced esophageal squamous cell carcinoma treated with trimodality therapy according to the Dutch ChemoRadiotherapy for Oesophageal cancer followed by Surg...
Autores principales: | So, Tsz Him, Chan, Sik Kwan, Chan, Wing Lok, Choi, Horace, Chiang, Chi Leung, Lee, Victor, Lam, Tai Chung, Wong, Ian, Law, Simon, Kwong, Dora, Ming (Spring) Kong, Feng, Jin, Jian Yue, Lam, Ka On |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7560564/ https://www.ncbi.nlm.nih.gov/pubmed/33089018 http://dx.doi.org/10.1016/j.adro.2020.03.021 |
Ejemplares similares
-
Third-line systemic treatment in advanced/metastatic gastric cancer:
a comprehensive review
por: Chan, Wing-lok, et al.
Publicado: (2019) -
Histological Regression of Squamous Esophageal Carcinoma Assessed by Percentage of Residual Viable Cells after Neoadjuvant Chemoradiation is an Important Prognostic Factor
por: Tong, Daniel King Hung, et al.
Publicado: (2010) -
Lymphopenia during chemoradiation—foe or friend
por: Patil, Vijay M, et al.
Publicado: (2020) -
Predicting liver and lung metastasis in esophageal cancer: does the site of primary tumor really matter?
por: Lam, Ka-On, et al.
Publicado: (2020) -
Splenic irradiation contributes to grade ≥ 3 lymphopenia after adjuvant chemoradiation for stomach cancer
por: Lee, Shing Fung, et al.
Publicado: (2022)